Clinical Trial Update: A Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Biliary Tract Cancer, Or Solid Tumors With Hepatic Metastases [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, pharmacokinetics, pharmacodynamics, and preliminary clinical activity of RO7119929 (TLR7 agonist) in participants with unresecta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Hepatocellular Carcinoma
• Liver Metastases

Drugs mentioned

• RO7119929

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Carcinoma, Hepatocellular, Biliary Tract Cancer | Phase 1 | Status: COMPLETED | Results posted: 2024-12-09